LP(A) MEASUREMENT IN PRIMARY PREVENTION POPULATION MAY LEAD TO INCREASED UTILIZATION OF STATIN THERAPY, A REAL-WORLD EXPERIENCE

• Main Authors: Viet T Le (Author), Heidi T May (Author), Jeffrey L. Anderson (Author), Tami Bair (Author), Stacey Knight (Author), Benjamin D. Horne (Author), Kirk U Knowlton (Author)
• Format: Book
• Published: Elsevier, 2023-09-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Therapeutic Area: ASCVD/CVD Risk Reduction Background: Lp(a) is an important independent risk factor for ASCVD, and Lp(a) lowering therapies are in development. We evaluated Lp(a) trends to review impact of Lp(a) testing on utilization of lipid lowering therapies. Methods: Lp(a) is an important inde...